August 1, 2024Open Access

Supplemental Figure S4 from Enhancing Standard of Care Chemotherapy Efficacy Using DNA-Dependent Protein Kinase (DNA-PK) Inhibition in Preclinical Models of Ewing Sarcoma

Key points are not available for this paper at this time.

The DNA-PKi enhancement of EWS cells sensitivity to etoposide DNA-PK inhibition is a class effect

AI에게 질문

Bookmark

View Full Paper

Cite This Study

Collins et al. (Thu,) studied this question.

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AI에게 질문

Bookmark

View Full Paper